3PETRIKKOS G, SKIADA A, SAM- BATAKOU H, et al. Mucormysis: ten - year experience at a tertiary - care center in Greece[J]. Eur J Clin Microbiol In- fect Dis, 2003, 22(12) : 753 -756.
4JACOBS P, WOOD L, DU TOIT A, et al. Eradication of invasive mucormycisis -effectiveness of the Echinocandin FK463[J]. Hematology, 2003, 8(2): 119 - 123.
5SPELLBERG B, FU Y, EDWARDS J E Jr, et al. Combination therapy with am- photericin B lipid complex and caspo 血. ngin acetate of disseminated zygomycosis in diabetic ketoacidotic mice [ J ]. Antimicrob Agents Chemother, 2005, 49 (2) : 830 -832.
2TALMI Y P, GOLDSCHMIEDREOUVEN A, BA KON M,et al . Rhino-orbital and rhino-orbito-cerebral mucormycosis[J].Otolaryngol Head Neck Surg,2002,127:22-31.
3PETERSON K L,WANG M, CANALIS R F, et al. Rhinocerebral mucormycosis: evolution of the disease and treatment options[J]. Laryngoscope, 1997,107: 855-862.
4CHUN S F S, STEVENS D A. Mueormycosis[M]// BENNETT J C, PLUM F, eds. Cecil textbook of medicine. 20th ed. London:Saunders, 1996:1832-1834.
5YOHAI R A, BULLOCK J D, AZIZ A A, et al . Survival factors in rhinoorbital cerebral mucormycosis[J]. Surv Ophthalmol,1994,39:3-22.
6ANAISSIE E J, SHIRBANI A H. Rhinocerebral mucormycosis with internal carotid occlusion report of two cases and review of the literature[J]. Laryncgoscope, 1985,95 : 1107-1113.
7HARRIL W C, STEWART M G, LEE A G, et al. Chronic rhinocerebral mucormycosis [J].Laryngoscope, 1996,106 : 1292-1297.
8TEDDER M, SPRATT J A, ANSTADT M P, et al. Pulmonarymucomycosis result of medical and surgical therapy[J]. Ann Thorac Surg, 1994,57 : 1044 - 1044.
9WALDORF A R, RUDERMAN N, DIAMOND R D. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus[J]. J Clin Invest, 1984,74 :150-160.
10LANGFORD J D, MCCARTNEY D L,WANG R C. Frozen sectionguided surgical debridement for management of rhino-orbital mucormycosis[J]. Am J Ophthalmol, 1997,124 : 265-267.
